Status:
NOT_YET_RECRUITING
POTASSIUM-RICH SALT SUBSTITUTES IN KIDNEY TRANSPLANT RECIPIENTS
Lead Sponsor:
University Medical Centre Ljubljana
Conditions:
Hypertension Arterial
Kidney Transplant
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Excessive sodium intake and inadequate potassium intake in the diet are known risk factors for the development of arterial hypertension and an increased risk of cardiovascular events. Data from random...
Detailed Description
Cardiovascular disease is the leading cause of morbidity and mortality worldwide, especially in patients with chronic kidney disease and kidney transplantation. Arterial hypertension is one of the mos...
Eligibility Criteria
Inclusion
- patients with a transplanted kidney ≥ 3 months post kidney-transplant
- a functioning transplanted kidney with estimated glomerular filtration rate (eGFR) according to CKD/EPI equation of at least 25 ml/min
- Elevated blood pressure/hypertension at the time of examination at the Kidney Transplantation Center outpatient clinic, determined by standardized blood pressure measurement (RR ≥ 130/80 mmHg)
- Age ≥ 18 years
Exclusion
- eGFR according to CKD/EPI equation below 25 ml/min
- serum potassium \> 5 mmol/l
- history of unexplained hyperkalemia
- pregnancy or planning of pregnancy
- inability to provide informed consent or to participate in the study (mental retardation, psychiatric illness in an uncontrolled phase)
- multiple organ transplantation
- Consuming most of daily meals outside the home environment
Key Trial Info
Start Date :
October 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 30 2026
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT07178964
Start Date
October 1 2025
End Date
September 30 2026
Last Update
September 17 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Medical Centre Ljubljana
Ljubljana, Slovenia, 1000